Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders

Research Grants 10 show all


$9M
2011

$1.2M
2014

$5.6M
2015

$2M
2016

$1.1M
2018

Publications 8 show all

  • 2
    Botulinum Toxins, Type A/chemistry
  • 2
    Botulinum Toxins/chemistry
  • 2
    Protein Engineering
  • 1
    Analgesics/therapeutic use
  • 1
    Biological Products/pharmacology
  • 1
    Botulinum Toxins, Type A/pharmacology
  • 1
    Botulinum Toxins/pharmacology
  • 1
    Botulinum Toxins/therapeutic use
  • 1
    Clostridium botulinum/chemistry
  • 1
    Drug Design

Patents 2,970show all

  • 707
    A61K - Preparations for medical, dental, or toilet purposes
  • 438
    C07K - Peptides
  • 266
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 245
    C07D - Heterocyclic compounds
  • 210
    C21D - Modifying the physical structure of ferrous metals
  • 136
    F27D - Details or accessories of furnaces, kilns, ovens, or retorts, in so far as they are of kinds occurring in more than one kind of furnace
  • 133
    F27B - Furnaces, kilns, ovens, or retorts in general
  • 131
    C12N - Microorganisms or enzymes
  • 109
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 70
    C23C - Coating metallic material

Clinical Trials 456show all

119N/A93Phase 384Phase 227Phase 420Phase 1/Phase 224Other

Contact Information

Boulogne-Billancourt
France